Trinity Biotech Announces Quarter 3 Financial Results

Go back to Trinity Biotech Announces Quarter 3 Financial Results

Craig-Hallum Downgrades Trinity Biotech (TRIB) to Hold

October 23, 2015 8:06 AM EDT

Craig-Hallum downgraded Trinity Biotech (NASDAQ: TRIB) from Buy to Hold with a price target of $14.00 (from $24.00).

For an analyst ratings summary and ratings history on Trinity Biotecjh click here. For more ratings news on Trinity Biotecjh click here.

Shares of Trinity Biotecjh closed at $13.02 yesterday.

... More

Trinity Biotech Plc (TRIB) Tops Q3 EPS by 1c

October 22, 2015 8:38 AM EDT

Trinity Biotech Plc (NASDAQ: TRIB) reported Q3 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $27.2 million versus the consensus estimate of $25.4 million.

For earnings history and earnings-related data on Trinity Biotech Plc (TRIB) click here.

... More